Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alissa Walsh

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Intestinal Research|August 10, 2018
What's app? Electronic health technology in inflammatory bowel diseaseAlissa Walsh, Simon Travis
Gastrointestinal Endoscopy Clinics of North America|July 1, 2014
Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activityAlissa Walsh, Rebecca Palmer, Simon Travis
European Journal of Gastroenterology & Hepatology|January 29, 2021
Stress-related consequences of the coronavirus disease 2019 pandemic on symptoms of Crohn's diseaseSarah M Goodday, Simon Travis, Alissa Walsh, et al.
Frontline Gastroenterology|August 15, 2023
Generalised urticaria and angioedema complicating switch back from subcutaneous to intravenous vedolizumab therapyDipesh Chauhan, Anil Prabhu, Sarah Cripps, et al.
The American Journal of Gastroenterology|March 12, 2025
Long-Term Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis: An Integrated 2-Year Safety AnalysisScott D Lee, Adam C Ehrlich, Paola Pellanda, et al.
Journal of Crohn'S & Colitis|July 18, 2018
Plasma Nuclear Magnetic Resonance Metabolomics Discriminates Between High and Low Endoscopic Activity and Predicts Progression in a Prospective Cohort of Patients With Ulcerative ColitisFay Probert, Alissa Walsh, Marta Jagielowicz, et al.
BMC Gastroenterology|March 23, 2021
Using item response theory (IRT) to improve the efficiency of the Simple Clinical Colitis Activity Index (SCCAI) for patients with ulcerative colitisAlissa Walsh, Rena Cao, Darren Wong, et al.
Intestinal Research|June 1, 2019
Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysisAlissa Walsh, Lawrence Matini, Christopher Hinds, et al.
Crohn'S & Colitis 360|July 1, 2025
Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative ColitisRemo Panaccione, Faye Chan-Diehl, Simin Baygani, et al.
Journal of Crohn'S & Colitis|November 17, 2018
Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective AnalysisAlissa Walsh, Andrey Kormilitzin, Christopher Hinds, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Intestinal Research|August 10, 2018
What's app? Electronic health technology in inflammatory bowel diseaseAlissa Walsh, Simon Travis
Gastrointestinal Endoscopy Clinics of North America|July 1, 2014
Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activityAlissa Walsh, Rebecca Palmer, Simon Travis
European Journal of Gastroenterology & Hepatology|January 29, 2021
Stress-related consequences of the coronavirus disease 2019 pandemic on symptoms of Crohn's diseaseSarah M Goodday, Simon Travis, Alissa Walsh, et al.
Frontline Gastroenterology|August 15, 2023
Generalised urticaria and angioedema complicating switch back from subcutaneous to intravenous vedolizumab therapyDipesh Chauhan, Anil Prabhu, Sarah Cripps, et al.
The American Journal of Gastroenterology|March 12, 2025
Long-Term Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis: An Integrated 2-Year Safety AnalysisScott D Lee, Adam C Ehrlich, Paola Pellanda, et al.
Journal of Crohn'S & Colitis|July 18, 2018
Plasma Nuclear Magnetic Resonance Metabolomics Discriminates Between High and Low Endoscopic Activity and Predicts Progression in a Prospective Cohort of Patients With Ulcerative ColitisFay Probert, Alissa Walsh, Marta Jagielowicz, et al.
BMC Gastroenterology|March 23, 2021
Using item response theory (IRT) to improve the efficiency of the Simple Clinical Colitis Activity Index (SCCAI) for patients with ulcerative colitisAlissa Walsh, Rena Cao, Darren Wong, et al.
Intestinal Research|June 1, 2019
Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysisAlissa Walsh, Lawrence Matini, Christopher Hinds, et al.
Crohn'S & Colitis 360|July 1, 2025
Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative ColitisRemo Panaccione, Faye Chan-Diehl, Simin Baygani, et al.
Journal of Crohn'S & Colitis|November 17, 2018
Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective AnalysisAlissa Walsh, Andrey Kormilitzin, Christopher Hinds, et al.
Pageof 4